Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAP Grazax Asthma Prevention
2009-011235-12Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Aug 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and seasonal allergic rhinitis (SAR) comparing Grazax with Placebo (2 arms). Primary endpoint: Time to onset of asthma during three treatment years. Started Aug 2009; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
asthmaseasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2009-011235-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011235-12.